Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
21.27
-0.19 (-0.89%)
At close: Dec 20, 2024, 4:00 PM
21.68
+0.41 (1.93%)
After-hours: Dec 20, 2024, 4:14 PM EST
Catalyst Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 142.8 | 71.41 | 83.08 | 39.48 | 74.98 | 31.88 | |
| Depreciation & Amortization | 37.46 | 32.88 | 1.24 | 0.19 | 0.09 | 0.06 | |
| Asset Writedown & Restructuring Costs | 2.23 | 81.51 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -1.95 | -3.02 | 0.76 | - | - | - | |
| Stock-Based Compensation | 21.33 | 14.25 | 7.91 | 6.07 | 6.26 | 3.83 | |
| Other Operating Activities | -11.41 | -16.11 | 9.33 | 9.6 | -32.19 | -0.05 | |
| Change in Accounts Receivable | -10.22 | -43.08 | -3.82 | -0.63 | 4.55 | -10.54 | |
| Change in Inventory | -10.98 | -4.74 | 1.07 | -3.22 | -2.69 | -1.9 | |
| Change in Accounts Payable | 6.97 | 10.82 | 1.21 | -1.49 | 0.14 | 1.78 | |
| Change in Other Net Operating Assets | 48.36 | -0.33 | 15.28 | 10.36 | -6.11 | 9.56 | |
| Operating Cash Flow | 224.58 | 143.6 | 116.05 | 60.37 | 45.03 | 34.61 | |
| Operating Cash Flow Growth | 75.41% | 23.74% | 92.22% | 34.06% | 30.11% | - | |
| Capital Expenditures | -36.56 | -198.52 | -10.03 | -1.02 | -0.01 | -0.02 | |
| Sale (Purchase) of Intangibles | -2.23 | -81.51 | - | - | - | - | |
| Investment in Securities | - | -13.47 | 19.24 | -10 | -5 | 37.24 | |
| Investing Cash Flow | -38.79 | -293.5 | 9.21 | -11.02 | -5.01 | 37.23 | |
| Issuance of Common Stock | 149.22 | 2.79 | 9.57 | 4.1 | 0.76 | 1.12 | |
| Repurchase of Common Stock | -0.66 | -0.98 | -7.14 | -12.24 | -0.06 | - | |
| Other Financing Activities | -13 | -12.67 | -0.74 | - | - | - | |
| Financing Cash Flow | 135.57 | -10.86 | 1.69 | -8.14 | 0.7 | 1.12 | |
| Net Cash Flow | 321.36 | -160.76 | 126.95 | 41.21 | 40.73 | 72.95 | |
| Free Cash Flow | 188.02 | -54.92 | 106.02 | 59.35 | 45.02 | 34.59 | |
| Free Cash Flow Growth | - | - | 78.63% | 31.82% | 30.15% | - | |
| Free Cash Flow Margin | 40.83% | -13.79% | 49.49% | 42.14% | 37.81% | 33.81% | |
| Free Cash Flow Per Share | 1.54 | -0.48 | 0.95 | 0.55 | 0.42 | 0.33 | |
| Cash Interest Paid | 1.36 | 0.71 | - | - | - | - | |
| Cash Income Tax Paid | 60.49 | 50.46 | 7.67 | 3 | 2.79 | - | |
| Levered Free Cash Flow | 150.67 | -219.49 | 89.69 | 42.14 | 28.96 | 22.9 | |
| Unlevered Free Cash Flow | 150.67 | -219.49 | 89.69 | 42.14 | 28.96 | 22.9 | |
| Change in Net Working Capital | -21.94 | 40.84 | -26.93 | -4.15 | 3.19 | 0.85 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.